Cart
sales@molnova.com
TCPOBOP
CAS No. 76150-91-9
TCPOBOP( —— )
Catalog No. M24766 CAS No. 76150-91-9
TCPOBOP is a constitutive androstane receptor agonist that induces robust hepatocyte proliferation and hepatomegaly.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 41 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 113 | In Stock |
|
| 50MG | 186 | In Stock |
|
| 100MG | 295 | In Stock |
|
| 200MG | 443 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTCPOBOP
-
NoteResearch use only, not for human use.
-
Brief DescriptionTCPOBOP is a constitutive androstane receptor agonist that induces robust hepatocyte proliferation and hepatomegaly.
-
DescriptionTCPOBOP is a constitutive androstane receptor agonist that induces robust hepatocyte proliferation and hepatomegaly. TCPOBOP decreases Fas-induced murine liver injury by altering Bcl-2 proteins.
-
In Vitro——
-
In VivoTCPOBOP (oral; 3 mg/kg; 1-5 days) remarkable increases Liver weight to body weight in LW/BW ratio at 48 hours. Animal Model:METfl/fl: Tam-Cre+/+ mice with a targeted deletion for exon 16 with MET KO Dosage:3 mg/kg.Administration:Oral; 1, 2, 5 days Result:Increased Liver weight to body weight.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBcl-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number76150-91-9
-
Formula Weight402.06
-
Molecular FormulaC16H8Cl4N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:25 mg/mL?(62.18 mM;?ultrasonic and warming and heat to 50°C)
-
SMILESClC1=CN=C(OC2=CC=C(OC3=NC=C(Cl)C=C3Cl)C=C2)C(Cl)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bhushan B, et al. TCPOBOP-Induced Hepatomegaly and Hepatocyte Proliferation are Attenuated by Combined Disruption of MET and EGFR Signaling. Hepatology. 2019 Apr;69(4):1702-1718.
molnova catalog
related products
-
Disarib
Disarib is a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain.
-
CID5721353
BCL6 inhibitor 79-6 (Compound 79-6) is the first-generation, specific BCL6 BTB domain inhibitor with IC50 of 200 uM, Kd of 129 uM.
-
Mcl-1-Puma inhibitor...
Mcl-1-Puma inhibitor 8 is a small-molecule dual-acting compound that targets the apoptotic Mcl-1-PUMA interface with Ki of 0.3 uM (Mcl-1, FPA).
